Drugs / HIV hyperimmune globulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00000590 | Sep 1991 → Dec 1996 | AIDS | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HIV hyperimmune globulin | “HIV hyperimmune globulin (HIVIG)” NCT00000590 ↗ |
| Known as | HIVIG | “HIV hyperimmune globulin (HIVIG)” NCT00000590 ↗ |
| Modality | Protein / enzyme biologic | “HIV hyperimmune globulin (HIVIG)” NCT00000590 ↗ |
| Route | Intravenous | “given intravenous HIVIG every four weeks until delivery” NCT00000590 ↗ |